JP2001524962A5 - - Google Patents

Download PDF

Info

Publication number
JP2001524962A5
JP2001524962A5 JP1998545925A JP54592598A JP2001524962A5 JP 2001524962 A5 JP2001524962 A5 JP 2001524962A5 JP 1998545925 A JP1998545925 A JP 1998545925A JP 54592598 A JP54592598 A JP 54592598A JP 2001524962 A5 JP2001524962 A5 JP 2001524962A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998545925A
Other languages
English (en)
Japanese (ja)
Other versions
JP4347914B2 (ja
JP2001524962A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/005791 external-priority patent/WO1998042343A1/en
Publication of JP2001524962A publication Critical patent/JP2001524962A/ja
Publication of JP2001524962A5 publication Critical patent/JP2001524962A5/ja
Application granted granted Critical
Publication of JP4347914B2 publication Critical patent/JP4347914B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP54592598A 1997-03-26 1998-03-24 慢性気管支炎の治療方法 Expired - Fee Related JP4347914B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4210197P 1997-03-26 1997-03-26
US60/042,101 1997-03-26
PCT/US1998/005791 WO1998042343A1 (en) 1997-03-26 1998-03-24 Method for treatment of chronic bronchitis

Publications (3)

Publication Number Publication Date
JP2001524962A JP2001524962A (ja) 2001-12-04
JP2001524962A5 true JP2001524962A5 (enExample) 2005-11-10
JP4347914B2 JP4347914B2 (ja) 2009-10-21

Family

ID=21920055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54592598A Expired - Fee Related JP4347914B2 (ja) 1997-03-26 1998-03-24 慢性気管支炎の治療方法

Country Status (8)

Country Link
US (1) US5972988A (enExample)
EP (1) EP1007046A4 (enExample)
JP (1) JP4347914B2 (enExample)
AU (1) AU6771798A (enExample)
CA (1) CA2284757A1 (enExample)
MY (1) MY114942A (enExample)
WO (1) WO1998042343A1 (enExample)
ZA (1) ZA982454B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2308443A1 (en) * 1997-10-27 1999-05-06 Michael Lyle Denney Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
EP1030661A4 (en) * 1997-10-27 2002-07-17 Lilly Co Eli N, N-DIETHYLGLYCOLAMIDOESTER OF INDOLS AS PRELIMINARY MEDICINE OF SPLA 2 INHIBITORS
CZ302588B6 (cs) * 1998-04-02 2011-07-27 Ziopharm Oncology, Inc. Použití N-substituovaného indol-3-glyoxylamidu pro výrobu léciva
US6576654B1 (en) * 1998-09-23 2003-06-10 Eli Lilly And Company Method for the treatment of cystic fibrosis
US6274578B1 (en) 1999-04-20 2001-08-14 Eli Lilly And Company sPLA2 inhibitor ester
US6140327A (en) * 1999-05-12 2000-10-31 Eli Lilly And Company Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
WO2001044185A1 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Carbon monoxide-based synthesis of spla2 inhibitors
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
WO2001081306A2 (en) * 2000-04-19 2001-11-01 Eli Lilly And Company Azide cyclization-based synthesis and intermediates for spla2 inhibitors
US20060035811A1 (en) * 2002-10-18 2006-02-16 Luis Molina Methods of treating dry eye disease with lantibiotics
CN1747936A (zh) * 2003-02-12 2006-03-15 特兰斯泰克制药公司 作为治疗试剂的取代吡咯衍生物
CA2565457A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
CA2565545A1 (en) * 2004-05-06 2005-12-08 Molichem Medicines, Inc. Treatment of ocular diseases and disorders using lantibiotic compositions
US20150338425A1 (en) * 2011-11-14 2015-11-26 The Brigham And Women's Hospital, Inc. Treatment and prognosis of lymphangioleiomyomatosis
US9925202B2 (en) 2013-03-04 2018-03-27 Brigham And Women's Hospital, Inc. Treatment of lymphangioleiomyomatosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2341045A1 (en) * 1994-04-01 2011-07-06 Eli Lilly and Company [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid (acyloxy)alkyl or ((alkoxycarbonyl)oxy)alkyl ester as SPLA2 inhibitor

Similar Documents

Publication Publication Date Title
JP2000507042A5 (enExample)
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000509912A5 (enExample)
JP2001524231A5 (enExample)
JP2001509291A5 (enExample)
JP2001500772A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2001500532A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2000507434A5 (enExample)
JP2000508880A5 (enExample)
JP2001524962A5 (enExample)
JP2001526637A5 (enExample)
JP2000509958A5 (enExample)
JP2000510792A5 (enExample)